151 related articles for article (PubMed ID: 38675711)
1. Effects of Red Sorghum-Derived Deoxyanthocyanidins and Their O-β-D-Glucosides on E-Cadherin Promoter Activity in PC-3 Prostate Cancer Cells.
Mora N; Rosa M; Touaibia M; Martin LJ
Molecules; 2024 Apr; 29(8):. PubMed ID: 38675711
[TBL] [Abstract][Full Text] [Related]
2. Analogs of Natural 3-Deoxyanthocyanins: O-Glucosides of the 4',7-Dihydroxyflavylium Ion and the Deep Influence of Glycosidation on Color.
Basílio N; Al Bittar S; Mora N; Dangles O; Pina F
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775619
[TBL] [Abstract][Full Text] [Related]
3. N-cadherin increases after androgen deprivation and is associated with metastasis in prostate cancer.
Jennbacken K; Tesan T; Wang W; Gustavsson H; Damber JE; Welén K
Endocr Relat Cancer; 2010 Jun; 17(2):469-79. PubMed ID: 20233707
[TBL] [Abstract][Full Text] [Related]
4. Skp2 and Slug Are Coexpressed in Aggressive Prostate Cancer and Inhibited by Neddylation Blockade.
Mickova A; Kharaishvili G; Kurfurstova D; Gachechiladze M; Kral M; Vacek O; Pokryvkova B; Mistrik M; Soucek K; Bouchal J
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799604
[TBL] [Abstract][Full Text] [Related]
5. Activation of estrogen receptor beta (ERβ) regulates the expression of N-cadherin, E-cadherin and β-catenin in androgen-independent prostate cancer cells.
Silva RS; Lombardi APG; de Souza DS; Vicente CM; Porto CS
Int J Biochem Cell Biol; 2018 Mar; 96():40-50. PubMed ID: 29341930
[TBL] [Abstract][Full Text] [Related]
6. The comprehensive role of E-cadherin in maintaining prostatic epithelial integrity during oncogenic transformation and tumor progression.
Olson A; Le V; Aldahl J; Yu EJ; Hooker E; He Y; Lee DH; Kim WK; Cardiff RD; Geradts J; Sun Z
PLoS Genet; 2019 Oct; 15(10):e1008451. PubMed ID: 31658259
[TBL] [Abstract][Full Text] [Related]
7. Metformin inhibits epithelial-mesenchymal transition in prostate cancer cells: involvement of the tumor suppressor miR30a and its target gene SOX4.
Zhang J; Shen C; Wang L; Ma Q; Xia P; Qi M; Yang M; Han B
Biochem Biophys Res Commun; 2014 Sep; 452(3):746-52. PubMed ID: 25201727
[TBL] [Abstract][Full Text] [Related]
8. Rosuvastatin inhibit spheroid formation and epithelial-mesenchymal transition (EMT) in prostate cancer PC-3 cell line.
Deezagi A; Safari N
Mol Biol Rep; 2020 Nov; 47(11):8727-8737. PubMed ID: 33085048
[TBL] [Abstract][Full Text] [Related]
9. Targeting the Nuclear Cathepsin L CCAAT Displacement Protein/Cut Homeobox Transcription Factor-Epithelial Mesenchymal Transition Pathway in Prostate and Breast Cancer Cells with the Z-FY-CHO Inhibitor.
Burton LJ; Dougan J; Jones J; Smith BN; Randle D; Henderson V; Odero-Marah VA
Mol Cell Biol; 2017 Mar; 37(5):. PubMed ID: 27956696
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of epithelial and mesenchymal proteins in a panel of prostate cancer cell lines.
Murali AK; Norris JS
J Urol; 2012 Aug; 188(2):632-8. PubMed ID: 22704442
[TBL] [Abstract][Full Text] [Related]
11. Novel pyrano and vinylphenol adducts of deoxyanthocyanidins in sorghum sourdough.
Bai Y; Findlay B; Maldonado AF; Schieber A; Vederas JC; Gänzle MG
J Agric Food Chem; 2014 Nov; 62(47):11536-46. PubMed ID: 25370078
[TBL] [Abstract][Full Text] [Related]
12. Metformin represses cancer cells via alternate pathways in N-cadherin expressing vs. N-cadherin deficient cells.
Ge R; Wang Z; Wu S; Zhuo Y; Otsetov AG; Cai C; Zhong W; Wu CL; Olumi AF
Oncotarget; 2015 Oct; 6(30):28973-87. PubMed ID: 26359363
[TBL] [Abstract][Full Text] [Related]
13. Cyanidin-3-glucoside induces mesenchymal to epithelial transition via activating Sirt1 expression in triple negative breast cancer cells.
Liang L; Liu X; He J; Shao Y; Liu J; Wang Z; Xia L; Han T; Wu P
Biochimie; 2019 Jul; 162():107-115. PubMed ID: 30876970
[TBL] [Abstract][Full Text] [Related]
14. Metformin mediated reversal of epithelial to mesenchymal transition is triggered by epigenetic changes in E-cadherin promoter.
Banerjee P; Surendran H; Chowdhury DR; Prabhakar K; Pal R
J Mol Med (Berl); 2016 Dec; 94(12):1397-1409. PubMed ID: 27534967
[TBL] [Abstract][Full Text] [Related]
15. Antioxidant properties of 3-deoxyanthocyanidins and polyphenolic extracts from Côte d'Ivoire's red and white sorghums assessed by ORAC and in vitro LDL oxidisability tests.
Carbonneau MA; Cisse M; Mora-Soumille N; Dairi S; Rosa M; Michel F; Lauret C; Cristol JP; Dangles O
Food Chem; 2014 Feb; 145():701-9. PubMed ID: 24128534
[TBL] [Abstract][Full Text] [Related]
16. LncRNA UCA1 maintains the low-tumorigenic and nonmetastatic status by stabilizing E-cadherin in primary prostate cancer cells.
Zhao X; Wang Y; He J; Deng R; Huang X; Guo Y; Li L; Xie R; Yu J
Mol Carcinog; 2020 Oct; 59(10):1174-1187. PubMed ID: 32805084
[TBL] [Abstract][Full Text] [Related]
17. The Wilms' tumor gene (WT1) regulates E-cadherin expression and migration of prostate cancer cells.
Brett A; Pandey S; Fraizer G
Mol Cancer; 2013 Jan; 12():3. PubMed ID: 23298185
[TBL] [Abstract][Full Text] [Related]
18. The antiproliferative activity of 3-deoxyanthocyanins extracted from red sorghum (Sorghum bicolor) bran through P(53)-dependent and Bcl-2 gene expression in breast cancer cell line.
Suganyadevi P; Saravanakumar KM; Mohandas S
Life Sci; 2013 Mar; 92(6-7):379-82. PubMed ID: 23333825
[TBL] [Abstract][Full Text] [Related]
19. Deguelin suppresses pancreatic tumor growth and metastasis by inhibiting epithelial-to-mesenchymal transition in an orthotopic model.
Boreddy SR; Srivastava SK
Oncogene; 2013 Aug; 32(34):3980-91. PubMed ID: 22986522
[TBL] [Abstract][Full Text] [Related]
20. Properties of 3-deoxyanthocyanins from sorghum.
Awika JM; Rooney LW; Waniska RD
J Agric Food Chem; 2004 Jul; 52(14):4388-94. PubMed ID: 15237941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
